市場調査レポート

商品コード

欧州の免疫診断市場の2030年予測-地域別分析：製品別、臨床適応症別、エンドユーザー別

Europe Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others), By Clinical Indication, and End User

出版日: 2023年11月07日
発行: The Insight Partners
ページ情報: 英文 209 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 3,450 497,007円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,450 641,067円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 5,450 785,127円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

欧州の免疫診断市場は、2023年の61億3,185万米ドルから2030年には100億9,803万米ドルに成長すると予測されています。2023～2030年のCAGRは7.4%と推定されます。

感染症の増加が欧州の免疫診断市場を牽引

ウイルス、真菌、細菌、寄生虫、またはそれらの毒性産物などの感染因子に起因する、増え続ける感染症の診断と管理は、免疫診断検査、例えば補体固定、沈殿検査、凝集検査、ラインブロットアッセイ、ウェスタンブロットアッセイ、酵素免疫測定（EIA）、免疫蛍光検査の処方数を急増させています。ヒト免疫不全ウイルス（HIV）は、世界的に公衆衛生上の大きな問題であり続けています。さらに、結核（TB）、COVID-19、その他の院内感染（HAI）には免疫診断学検査が必要です。

結核は死因の第13位であり、COVID-19に次いで第2位の感染症キラーです。2020年には150万人が結核で死亡し、世界で推定1,000万人（男性560万人、女性330万人、子供110万人）が罹患しています。

Worldometerによると、COVID-19の大流行により、世界中で数100万人の死亡が報告されました。このパンデミックは医療システムを疲弊させ、免疫診断学検査の必要性を高めました。

診断は、適切な治療法を決定する上で重要な役割を果たします。免疫診断は、免疫系に深刻な影響を与える疾患の診断に役立ちます。そのため、感染症の流行が増加し、免疫診断製品に対する需要が急増しています。

欧州の免疫診断市場概要

膨大な高齢者人口がドイツの免疫診断市場を大きく牽引しています。国連の人口データによると、ドイツ人の20人に1人が80歳以上の高齢者であり、その数は2050年までに20人に6人に増加すると予測されています。心血管疾患（CVD）、糖尿病、神経血管障害などの慢性疾患の発症リスクは、加齢とともに高まる。ロベルト・コッホ研究所が2023年9月に発表したドイツがん登録データセンター（ZfKD）の推定によると、ドイツでは2019年に50万2,655人ががんに罹患し、そのうち女性は23万4,925人、男性は26万7,730人だった。ライフスタイルの変化、肥満、不健康な生活習慣などにより、がんの有病率は今後も続くと推定されています。ドイツで最も多いがんは、乳がん、前立腺がん、大腸がん、肺がん、膀胱がんです。これら5種類のがんは、ドイツにおける新規がん診断の約57％を占めています。このように、がん罹患率の増加は免疫診断の需要を促進する可能性が高いです。

ドイツは米国に次いで世界有数の医療バイオテクノロジー国家です。2020年、ドイツのバイオテクノロジー部門はCOVID前の2018年に比べて大きく成長しました。一部の分野ではここ数年、プラスの市場動向が加速しており、BIOCOMによるOECD準拠の調査によると、ドイツのバイオテクノロジー産業の売上高は2020年に約50％増加しました。老舗企業の存在と新興企業の台頭が、産業の強さを裏付けています。産業、政府、研究部門は、強力な市場基盤の上で繁栄しています。多くの欧州バイオテクノロジー企業、世界トップクラスの研究インフラ、国際的に著名な科学者を擁するドイツは、国際的な医療バイオテクノロジーのハブとしての地位を確固たるものにしました。ドイツのバイオテクノロジー企業は、欧州医薬品庁から承認された最初のCOVID-19の検査とワクチン接種を導入することで、mRNA技術の世界的リーダーとして頭角を現しました。このような発展は、免疫診断学の技術的進歩を後押ししています。このように、バイオテクノロジー分野の台頭は、同国の免疫診断市場を押し上げる可能性が高いです。

欧州の免疫診断市場の収益と2030年までの予測（金額）

欧州の免疫診断市場のセグメンテーション

欧州の免疫診断市場は、製品、臨床適応症、エンドユーザー、国別に区分されます。

製品別に見ると、欧州の免疫診断市場は酵素結合免疫吸着測定法（ELISA）、化学発光免疫測定法（CLIA）、ラジオイムノアッセイ（RIA）、その他に区分されます。2023年には、酵素結合免疫吸着測定法（ELISA）分野が欧州の免疫診断市場で最大のシェアを記録しました。化学発光免疫測定法（CLIA）セグメントはさらに、ビタミンDアッセイ市場、HIV検出市場、HIV ag/abコンボアッセイ市場、その他の検査に区分されます。

臨床適応に基づき、欧州の免疫診断市場は感染症、肝炎+HIV、内分泌、消化器、代謝、その他に区分されます。2023年には、感染症分野が欧州の免疫診断市場で最大のシェアを記録しました。感染症分野はさらに、COVID-19、結核、ライム、感染管理、ジカ熱、トレポネーマ、トーチ、麻疹・おたふくかぜ、VZV、EBVに区分されます。内分泌分野はさらに、高血圧、成長、糖尿病、甲状腺、生殖内分泌に区分されます。

エンドユーザー別に見ると、欧州の免疫診断市場は病院、クリニック、診断研究所、学術・研究機関、その他に区分されます。2023年には、病院セグメントが欧州の免疫診断市場で最大のシェアを記録しました。

国別では、欧州の免疫診断市場はドイツ、フランス、英国、イタリア、スペイン、その他の欧州に区分されます。2023年には、ドイツセグメントが欧州の免疫診断市場で最大のシェアを記録しました。

Abbott Laboratories、bioMerieux SA、Danaher Corp、DiaSorin SpA、F. Hoffmann-La Roche Ltd、PerkinElmer Inc、Shenzhen Mindray Bio-Medical Electronics Co., Ltd.、Siemens Healthcare GmbH、Svar Life Science AB、and Thermo Fisher Scientific Inc.は、欧州の免疫診断市場に参入している大手企業です。

市場促進要因
- 感染症罹患率の増加
- ポイントオブケア免疫診断の利用拡大
市場抑制要因
- 不十分な償還シナリオ
市場機会
- 主要企業による研究開発投資と事業拡大への注目の高まり
今後の動向
- 免疫診断における技術の進歩
影響分析

第6章免疫診断市場：欧州分析

欧州の免疫診断市場の収益と予測分析

第7章欧州の免疫診断市場分析-製品別

イントロダクション
欧州の免疫診断市場：製品別、2022年・2030年（%）
酵素結合免疫吸着測定法（ELISA）
化学発光免疫測定法（CLIA）
ラジオイムノアッセイ（RIA）
その他

第8章欧州の免疫診断市場分析：臨床適応症

イントロダクション
欧州の免疫診断市場：臨床適応症別シェア、2022年・2030年（%）
感染症
- 概要
  - COVID-19
  - 結核
  - ライム
  - 感染症管理
  - ジカ熱
  - トレポネーマ
  - トーチ
  - 麻疹と流行性耳下腺炎
  - VZV
  - EBV
肝炎+HIV
概要
消化器
概要
代謝疾患
概要
内分泌学
- 概要
- 高血圧
- 概要
- 成長
- 概要
- 糖尿病
  - 糖尿病
- 甲状腺
  - 内分泌学
- 生殖内分泌学
  - 内分泌学
その他
- その他

第9章欧州の免疫診断市場分析：エンドユーザー

イントロダクション
欧州の免疫診断市場のエンドユーザー別シェア、2022年・2030年（%）
病院
- 病院
クリニック
概要
診断研究所
- 研究機関
学術・研究機関
概要
その他
概要

第10章欧州の免疫診断市場：2030年までの収益と予測：国別分析

第11章欧州の免疫診断市場欧州の免疫診断市場：業界情勢

イントロダクション
無機的成長戦略
概要
有機的成長戦略
概要

第12章企業プロファイル

Abbott Laboratories
F. Hoffmann-La Roche Ltd
DiaSorin SpA
Danaher Corp
Thermo Fisher Scientific Inc
PerkinElmer Inc
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
bioMerieux SA
Svar Life Science AB
Siemens Healthcare GmbH

第13章付録

図表

List Of Tables

Table 1. UK Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 2. UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 3. UK Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 4. UK Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 6. UK Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 8. Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 10. Germany: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 11. Germany Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 12. Germany Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. France Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 15. France Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 16. France: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 17. France Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 18. France Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 23. Italy Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 24. Italy Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 28. Spain: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 29. Spain Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 30. Spain Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Europe Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Europe Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Europe: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Europe Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Europe Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 37. Recent Inorganic Growth Strategies in the Europe immunodiagnostics market
Table 38. Recent Organic Growth Strategies in the Europe immunodiagnostics market
Table 39. Glossary of Terms, Europe Immunodiagnostics Market

List Of Figures

Figure 1. Europe Immunodiagnostics Market Segmentation
Figure 2. Europe Immunodiagnostics Market, by Country
Figure 3. Europe Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Europe Immunodiagnostics Market
Figure 5. The UK Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. Europe Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Immunodiagnostics Market - Revenue Forecast and Analysis - 2021-2030
Figure 10. Europe Immunodiagnostics Market, by Product, 2022 & 2030 (%)
Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 12. Chemiluminescence Immunoassays (CLIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 13. Vitamin D Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 14. HIV Detection: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 15. HIV Ag/Ab Combo Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 16. Other Tests: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 17. Radioimmunoassays (RIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
Figure 20. Infectious Diseases: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. COVID-19: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Tuberculosis: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. Lyme: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. Infection Management: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 25. Zika: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 26. Treponema: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 27. TORCH: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 28. Measles and Mumps: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 29. VZV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 30. EBV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Hepatitis+HIV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 32. Gastrointestinal: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. Metabolics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 34. Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 35. Hypertension: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 36. Growth: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diabetes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. Thyroid: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. Reproductive Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 41. Europe Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
Figure 42. Hospitals: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 43. Clinics: Europe Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
Figure 44. Diagnostic Laboratories: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 45. Academic and Research Institutes: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 46. Others: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 47. Europe: Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 48. Europe: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 49. UK: Immunodiagnostics market - Revenue and Forecast to 2030 (US$ Million)
Figure 50. Germany: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. France: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 52. Italy: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 53. Spain: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 54. Rest of Europe: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Product Code: BMIRE00027867

The Europe immunodiagnostics market is expected to grow from US$ 6,131.85 million in 2023 to US$ 10,098.03 million by 2030. It is estimated to grow at a CAGR of 7.4% from 2023 to 2030.

Increasing Prevalence of Infectious Diseases Drive Europe Immunodiagnostics Market

The diagnosis and management of several ever-growing infectious diseases caused by infectious agents such as viruses, fungi, bacteria, parasites, or their toxic products are surging number of prescriptions for immunodiagnostics tests, e.g., complement fixation, precipitation tests, agglutination tests, line blot assays, Western blot assays, enzyme immunoassays (EIA), and immunofluorescence tests. Human immunodeficiency virus (HIV) continues to be a major public health issue worldwide. Further, tuberculosis (TB), COVID-19, and other hospital-acquired infections (HAIs) require immunodiagnostics tests.

TB has been the 13th leading cause of death and the second-leading infectious killer after COVID-19. In 2020, 1.5 million people died from TB and affected an estimated 10 million people, comprising 5.6 million males, 3.3 million females, and 1.1 million children globally.

According to Worldometer, millions of deaths were reported worldwide due to the COVID-19 pandemic. It strained healthcare systems and increased the need for immunodiagnostics tests.

Diagnostics play a vital role in determining suitable medical treatments. Immunodiagnostics help diagnose diseases that severely impact the immune system. Hence, the rising prevalence of infectious diseases lead to the surging demand for immunodiagnostics products.

Europe Immunodiagnostics Market Overview

The huge geriatric population is significantly driving the market for immunodiagnostics in Germany. According to the UN population data, 1 out of 20 Germans is aged above 80 years, and the number is expected to increase to 6 out of 20 by 2050. The risk of developing chronic diseases, such as cardiovascular diseases (CVDs), diabetes, and neurovascular disorders, increases with age. According to the estimates of the German Centre for Cancer Registry Data (ZfKD) published by the Robert Koch Institute in September 2023, in Germany, 502,655 people had cancer in 2019, among which 234,925 were women and 267,730 were men. It is estimated that the prevalence of cancer is likely to continue owing to lifestyle changes, obesity, unhealthy habits, and more. The most common cancers in Germany are breast, prostate, colorectum (large bowel), lung, and bladder cancer. These five cancer types accounted for about 57% of all new cancer diagnoses in Germany. Thus, the increasing prevalence of cancer is likely to propel the demand for immunodiagnostics.

Germany is the leading medical biotech nation in the world after the US. In 2020, the German biotechnology sector grew significantly compared to the pre-COVID year 2018. The positive market trend has accelerated in the last few years in some areas; and according to the OECD-compliant survey by BIOCOM, the German biotechnology industry's turnover increased by almost 50% in 2020. The presence of long-established companies and the emergence of start-ups affirmed the industrial strength. Industry, government, and research sectors thrive on strong market foundations. With many European biotech companies, world-class research infrastructure, and internationally renowned scientists, Germany has firmly established itself as an international medical biotechnology hub. German biotech companies emerged as global leaders in mRNA technologies by introducing the first COVID-19 test and vaccination, approved by the European Medicines Agency. Such developments have encouraged enhanced technological advancements for immunodiagnostics. Thus, the rising biotechnology sector will likely boost the country's immunodiagnostics market.

Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe Immunodiagnostics Market Segmentation

The Europe immunodiagnostics market is segmented into product, clinical indication, end user, and country.

Based on product, the Europe immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. In 2023, the enzyme-linked immunosorbent assays (ELISA) segment registered the largest share in the Europe immunodiagnostics market. The chemiluminescence immunoassays (CLIA) segment is further segmented into vitamin D assay market, HIV detection market, HIV ag/ab combo assay market, and other tests.

Based on clinical indication, the Europe immunodiagnostics market is segmented into infectious diseases, hepatitis+hiv, endocrinology, gastrointestinal, metabolics, and others. In 2023, the infectious diseases segment registered the largest share in the Europe immunodiagnostics market. The infectious diseases segment is further segmented into COVID-19, tuberculosis, lyme, infection management, zika, treponema, torch, measles and mumps, VZV, and EBV. The endocrinology segment is further segmented into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.

Based on end user, the Europe immunodiagnostics market is segmented into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. In 2023, the hospitals segment registered the largest share in the Europe immunodiagnostics market.

Based on country, the Europe immunodiagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. In 2023, Germany segment registered the largest share in the Europe immunodiagnostics market.

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin SpA; F. Hoffmann-La Roche Ltd; PerkinElmer Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Svar Life Science AB; and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe immunodiagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe immunodiagnostics market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe immunodiagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the immunodiagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Immunodiagnostics Market - by Product
- 1.3.2 Europe Immunodiagnostics Market - by Clinical Indication
- 1.3.3 Europe Immunodiagnostics Market - by End User
- 1.3.4 Europe Immunodiagnostics Market - by Country

2. Europe Immunodiagnostics Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Immunodiagnostics Market - Market Landscape

4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert's Opinion

5. Europe Immunodiagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Infectious Diseases
- 5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
- 5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
- 5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
- 5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis

6. Immunodiagnostics Market - Europe Analysis

6.1 Europe Immunodiagnostics Market Revenue Forecast and Analysis

7. Europe Immunodiagnostics Market Analysis - by Product

7.1 Overview
7.2 Europe Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
- 7.3.1 Overview
- 7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
- 7.4.1 Overview
- 7.4.2 Chemiluminescence Immunoassays (CLIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Vitamin D Assay
  - 7.4.3.1 Overview
  - 7.4.3.2 Vitamin D Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 HIV Detection
  - 7.4.4.1 Overview
  - 7.4.4.2 HIV Detection: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.5 HIV Ag/Ab Combo assay
  - 7.4.5.1 Overview
  - 7.4.5.2 HIV Ag/Ab Combo Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.6 Other Tests
  - 7.4.6.1 Overview
  - 7.4.6.2 Other Tests: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
- 7.5.1 Overview
- 7.5.2 Radioimmunoassays (RIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. Europe Immunodiagnostics Market Analysis - Clinical Indication

8.1 Overview
8.2 Europe Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
8.3 Infectious Diseases:
- 8.3.1 Overview
- 8.3.2 Infectious Diseases: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 COVID-19
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 COVID-19: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.2 Tuberculosis
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Tuberculosis: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.3 Lyme
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Lyme: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.4 Infection Management
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Infection Management: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.5 Zika
    - 8.3.2.5.1 Overview
    - 8.3.2.5.2 Zika: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.6 Treponema
    - 8.3.2.6.1 Overview
    - 8.3.2.6.2 Treponema: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.7 TORCH
    - 8.3.2.7.1 Overview
    - 8.3.2.7.2 TORCH: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.8 Measles and Mumps
    - 8.3.2.8.1 Overview
    - 8.3.2.8.2 Measles and Mumps: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.9 VZV
    - 8.3.2.9.1 Overview
    - 8.3.2.9.2 VZV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.10 EBV
    - 8.3.2.10.1 Overview
    - 8.3.2.10.2 EBV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
- 8.4.1 Overview
- 8.4.2 Hepatitis+HIV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
- 8.5.1 Overview
- 8.5.2 Gastrointestinal: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
- 8.6.1 Overview
- 8.6.2 Metabolics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
- 8.7.1 Overview
- 8.7.2 Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.3 Hypertension
  - 8.7.3.1 Overview
  - 8.7.3.2 Hypertension: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.4 Growth
  - 8.7.4.1 Overview
  - 8.7.4.2 Growth: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.5 Diabetes
  - 8.7.5.1 Overview
  - 8.7.5.2 Diabetes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.6 Thyroid
  - 8.7.6.1 Overview
  - 8.7.6.2 Thyroid: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.7 Reproductive Endocrinology
  - 8.7.7.1 Overview
  - 8.7.7.2 Reproductive Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. Europe Immunodiagnostics Market Analysis - End User

9.1 Overview
9.2 Europe Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
- 9.4.1 Overview
- 9.4.2 Clinics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Diagnostic Laboratories: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
- 9.6.1 Overview
- 9.6.2 Academic and Research Institutes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. Europe Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Overview

11. Europe Immunodiagnostics Market -Industry Landscape

11.1 Overview
11.2 Inorganic Growth Strategies
- 11.2.1 Overview
11.3 Organic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 DiaSorin SpA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Danaher Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 PerkinElmer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 bioMerieux SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Svar Life Science AB
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Siemens Healthcare GmbH
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

欧州の免疫診断市場の2030年予測-地域別分析：製品別、臨床適応症別、エンドユーザー別

Europe Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others), By Clinical Indication, and End User

目次

第1章イントロダクション

第2章欧州の免疫診断市場-要点

第3章調査手法

第4章欧州の免疫診断市場-市場情勢

第5章欧州の免疫診断市場-主要市場力学

第6章免疫診断市場：欧州分析

第7章欧州の免疫診断市場分析-製品別

第8章欧州の免疫診断市場分析：臨床適応症

第9章欧州の免疫診断市場分析：エンドユーザー

第10章欧州の免疫診断市場：2030年までの収益と予測：国別分析

第11章欧州の免疫診断市場欧州の免疫診断市場：業界情勢

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Europe Immunodiagnostics Market - Key Takeaways

3. Research Methodology

4. Europe Immunodiagnostics Market - Market Landscape

5. Europe Immunodiagnostics Market - Key Market Dynamics

6. Immunodiagnostics Market - Europe Analysis

7. Europe Immunodiagnostics Market Analysis - by Product

8. Europe Immunodiagnostics Market Analysis - Clinical Indication

9. Europe Immunodiagnostics Market Analysis - End User

10. Europe Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis

11. Europe Immunodiagnostics Market -Industry Landscape

12. Company Profiles

13. Appendix

欧州の免疫診断市場の2030年予測-地域別分析：製品別、臨床適応症別、エンドユーザー別

Europe Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others), By Clinical Indication, and End User

目次

第1章 イントロダクション

第2章 欧州の免疫診断市場-要点

第3章 調査手法

第4章 欧州の免疫診断市場-市場情勢

第5章 欧州の免疫診断市場-主要市場力学

第6章 免疫診断市場：欧州分析

第7章 欧州の免疫診断市場分析-製品別

第8章 欧州の免疫診断市場分析：臨床適応症

第9章 欧州の免疫診断市場分析：エンドユーザー

第10章 欧州の免疫診断市場：2030年までの収益と予測：国別分析

第11章 欧州の免疫診断市場欧州の免疫診断市場：業界情勢

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Europe Immunodiagnostics Market - Key Takeaways

3. Research Methodology

4. Europe Immunodiagnostics Market - Market Landscape

5. Europe Immunodiagnostics Market - Key Market Dynamics

6. Immunodiagnostics Market - Europe Analysis

7. Europe Immunodiagnostics Market Analysis - by Product

8. Europe Immunodiagnostics Market Analysis - Clinical Indication

9. Europe Immunodiagnostics Market Analysis - End User

10. Europe Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis

11. Europe Immunodiagnostics Market -Industry Landscape

12. Company Profiles

13. Appendix

第1章イントロダクション

第2章欧州の免疫診断市場-要点

第3章調査手法

第4章欧州の免疫診断市場-市場情勢

第5章欧州の免疫診断市場-主要市場力学

第6章免疫診断市場：欧州分析

第7章欧州の免疫診断市場分析-製品別

第8章欧州の免疫診断市場分析：臨床適応症

第9章欧州の免疫診断市場分析：エンドユーザー

第10章欧州の免疫診断市場：2030年までの収益と予測：国別分析

第11章欧州の免疫診断市場欧州の免疫診断市場：業界情勢

第12章企業プロファイル

第13章付録